Use of continuous glucose monitoring to estimate insulin requirements in patients with type 1 diabetes mellitus during a short course of prednisone

Journal of Diabetes Science and Technology

Volumn 2, Issue 4, 2008, Pages 578-583

  Bevier, Wendy C ^a   Zisser, Howard C ^a,b   Jovanovič, Lois ^a,b   Finan, Daniel A ^a,b   Palerm, Cesar C ^b,c   Seborg, Dale E ^a,b   Doyle III, Francis J ^a,b  

^a SANSUM DIABETES RESEARCH INSTITUTE   (United States)

^b University of California   (United States)

^c MEDTRONIC INC   (United States)

Author keywords

Continuous glucose monitoring; Insulin requirements; Prednisone; Stress; Type 1 diabetes mellitus

Indexed keywords

EID: 77955129669     PISSN: None     EISSN: 19322968     Source Type: Journal    
DOI: 10.1177/193229680800200408     Document Type: Article

References (19)

1. Garg SK, Sharp LC, Stults ME. Glucose monitoring of the present and future. In: Fonseca VA, editor. Clinical Diabetes: Translating Research into Practice. Philadelphia: Saunders Elsevier; 2006. p. 442-57.
2. Jovanovic L. Insulin therapy and algorithms for treating type 1 diabetes mellitus. In: Optimizing insulin therapy in patients with diabetes, a CME activity jointly sponsored by Washington Hospital Center and MedStar Research Institute, Washington DC; 2002, p. 13-19.
3. Landis B, Jovanovic J, Landis E, et al. Effect of stress reduction on daily glucose range in previously stabilized insulin-dependent diabetic patients. Diabetes Care 1985;8(6):624-6.
4. Cannon W. B. Bodily changes in pain, hunger, fear and rage. 2nd ed. New York: Appleton; 1929.
5. Selye H. A syndrome produced by diverse nocuous agents. Nature 1936;138:32.
6. Riazi A, Pickup J, Bradley C. Daily stress and glycaemic control in type 1 diabetes: individual differences in magnitude, direction, and timing of stress-reactivity. Diabetes Res Clin Pract. 2004;66(3):237-44.
7. Kramer JR, Ledolter J, Manos GN, Bayless ML. Stress and metabolic control in diabetes mellitus: methodological issues and an illustrative analysis. Ann Behav Med. 2000;22(1):17-28.
8. Peirce NS. Diabetes and exercise. Br J Sports Med. 1999;33(3):161-72.
9. Walsh J, Roberts R. Pumping Insulin. 4th ed. San Diego: Torrey Pines Press; 2006.
10. Meikle AW, Weed JA, Tyler FH. Kinetics and interconversion of prednisolone and prednisone studied with new radioimmunoassays. J Clin Endocrinol Metab. 1975 Oct; 41(4):717-21.
11. Pickup ME. Clinical pharmacokinetics of prednisone and prednisilone. Clin Pharmacokinet. 1979;4(2):111-28.
12. Zisser H, Bevier W, Jovanovic L. Restoring euglycemia in the basal state using continuous glucose monitoring in subjects with type 1 diabetes mellitus. Diabetes Technol Ther. 2007;9(6):509-15.
13. Spielberger C. D. Manual of the State-Trait Anxiety Inventory. Rev. ed. Palo Alto: Consulting Psychologists Press; 1983.
14. Levine S, Stress: an historical perspective. In: Steckler T, Kalin NH, Reul JMHM. Handbook of stress and the brain. Part 1: The Neurobiology of Stress. Amsterdam: Elsevier, 2005:3-23.
15. Zarkovic M, Beleslin B, Ciric J, Penezic Z, Stojkovic M, Trbojevic B, Drezgic M, Savic S. Glucocorticoid effect on insulin sensitivity: a time frame. J Endocrinol Invest. 2008;31(3):238-42.
16. Qi D, Rodrigues B. Glucocorticoids produce whole body insulin resistance with changes in cardiac metabolism. Am J Physiol Endocrinol Metab 2007;292(3):E654-67.
17. Klaff LS, Wisse BE. Current controversy related to glucocorticoid and insulin therapy in the intensive care unit. Endocr Pract. 2007;13(5):542-9.
18. Van den Berghe G, Wouters P, Weekers F, Verwaest C, Bruyninckx F, Schetz M, Vlasselaers D, Ferdinande P, Lauwers P, Bouillon R. Intensive insulin therapy in the critically ill patients. N Engl J Med. 2001;345(19):1359-67.
19. Van den Berghe G, Wilmer A, Milants I, Wouters PJ, Bouckaert B, Bruyninckx F, Bouillon R, Schetz M. Intensive insulin therapy in mixed medical/surgical intensive care units: beneft versus harm. Diabetes. 2006;55(11):3151-9.